Conduit Pharmaceuticals Inc. (CDT)
NASDAQ: CDT · Real-Time Price · USD
0.7221
-0.0589 (-7.54%)
At close: Apr 1, 2025, 4:00 PM
0.7448
+0.0227 (3.15%)
After-hours: Apr 1, 2025, 4:24 PM EDT

Conduit Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-17.8-0.54-4.89-3.66
Depreciation & Amortization
0.46---
Other Amortization
0.93---
Loss (Gain) From Sale of Investments
-0.01-0.130.08
Stock-Based Compensation
1.830.2--
Other Operating Activities
5.05-4.631.570.07
Change in Accounts Payable
1.230.22--
Change in Other Net Operating Assets
-1.37-2.730.61.36
Operating Cash Flow
-9.68-7.73-2.27-2.15
Capital Expenditures
-0.05---
Investment in Securities
0.01---
Other Investing Activities
-0.73-0.18-
Investing Cash Flow
-0.040.73-0.18-
Short-Term Debt Issued
3.23---
Long-Term Debt Issued
-2.291.110.69
Total Debt Issued
3.232.291.110.69
Short-Term Debt Repaid
-0.78---
Total Debt Repaid
-0.78---
Net Debt Issued (Repaid)
2.452.291.110.69
Issuance of Common Stock
3.620.151.341.21
Other Financing Activities
-8.49--
Financing Cash Flow
6.0710.932.451.9
Foreign Exchange Rate Adjustments
-0.020.300
Net Cash Flow
-3.674.23--0.25
Free Cash Flow
-9.73-7.73-2.27-2.15
Free Cash Flow Per Share
-11.22-11.38-6.05-
Cash Interest Paid
-0.12--
Levered Free Cash Flow
-7.32---
Unlevered Free Cash Flow
-7.31---
Change in Net Working Capital
-1.92---
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q